Results 81 to 90 of about 68,693 (261)
This scoping review synthesizes evidence from 24 studies (2019–2024) to examine how AI‐powered chatbots address patients' and caregivers' health information needs across diseases. Findings highlight key benefits such as accessibility, empowerment, efficiency, and personalization, alongside important limitations related to empathy, language and ...
Julie Desgroseilliers +3 more
wiley +1 more source
Electrical stimulation for gastroesophageal reflux disease: current state of the art
Sharon E Kim, Edy Soffer Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA Abstract: Patients with gastroesophageal reflux disease (GERD) who are not satisfied with acid suppression therapy can ...
Kim SE, Soffer E
core
Background : Gastroesophageal reflux disease is a worldwide prevalent condition that exhibits a large variety of signs and symptoms of esophageal or extra-esophageal nature and can be related to the esophagic adenocarcinoma.
Ary NASI (6543914) +7 more
core +1 more source
Review of nutrition management of pediatric intestinal pseudo‐obstruction
Abstract Chronic intestinal pseudo‐obstruction (CIPO) is a rare, heterogeneous, and debilitating disorder characterized by profound intestinal dysmotility and severe nutrition challenges. Its presentation resembles that of mechanical bowel obstruction, but CIPO occurs in the absence of luminal obstruction.
Senthilkumar Sankararaman +5 more
wiley +1 more source
Prevalence of Pre‐Clinical Obesity Among US Adults Receiving Medical and Surgical Obesity Treatment
ABSTRACT Objective We sought to determine how the proportion of adults historically receiving obesity interventions would be classified under the recently proposed “pre‐clinical” and “clinical” obesity classifications and the impact of this change on safety and outcomes.
Jason M. Samuels +4 more
wiley +1 more source
Gastroesophageal reflux and dental consequences [PDF]
Background: Dentists are often the first health care professionals to diagnose dental consequences in patients with gastroesophageal reflux disease (GERD).
Toneva Stojmenova, Verica +5 more
core
Effectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency
ABSTRACT Setmelanotide, a melanocortin 4 receptor (MC4R) agonist, is a promising pharmacological treatment option for people with rare monogenic obesity conditions affecting the leptin‐melanocortin signaling pathway, including proprotein convertase subtilisin/kexin type 1 (PCSK1) gene mutations.
Ellina Lytvyak +2 more
wiley +1 more source
ABSTRACT Background Intravenous lidocaine therapy (IVLT) is often used in perioperative multimodal analgesia due to its analgesic, anti‐hyperalgesic, and anti‐inflammatory effects. In adults, IVLT doses of 1–2 mg/kg/h produce plasma concentrations of 1–2 μg/mL, within the presumed therapeutic range of 1–5 μg/mL.
McKenna Postles +3 more
wiley +1 more source
Abstract Myotonic dystrophy type 1 (DM1) is a clinically challenging multisystem neuromuscular hereditary disorder, with generational increase in severity and earlier age at onset. It is caused by an unstable cytosine‐thymine‐guanine repeat expansion at the DMPK locus, accompanied by associated genetic and epigenetic modifications.
Md Mehedi Hasan +9 more
wiley +1 more source

